Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Catalent plans $100 million biologics manufacturing expansion at Anagni

cphi-onlineJuly 22, 2021

Tag: Catalent , Anagni , COVID-19 Vaccines

PharmaSources Customer Service